A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

American Academy of Nursing Releases Position Statement on Firearm Safety and Violence Prevention

The American Academy of Nursing (Academy) has released a position statement on firearm safety and violence prevention. The Academy has long supported policies to reduce firearm violence. Firearm violence, from suicides to mass shootings, is an epidemic in the United States, and as such, a public health approach to addressing the causes and risk factors leading to violence is necessary to safeguard the health of the nation. The Academy’s position was built on current research, national statistics, and evidence-based recommendations.

This position statement was prepared by members of the Academy’s Expert Panels on Acute & Critical Care; Environmental & Public Health; Health Equity; Psychiatric, Mental Health, & Substance Use; and Violence. The Academy’s Expert Panels are the organization’s thought leadership bodies, consisting of Fellows with expertise in specific topic areas who maximize their analytical skills and networks to review the current trends, research, and issues within their field to make informed and evidence-based recommendations.

View the entire position statement online here.

Policy Recommendations
The Academy calls for a wide-reaching, evidence-based public health approach to address and prevent firearm-related violence and promote firearm safety, including distinguishing key factors that contribute to all types of firearm-related violence while identifying actionable solutions.

Strengthen the nursing and health workforce to conduct and lead health screenings, patient counseling, and family-, school-, and community-based violence prevention training and programs to address risk factors such as unintentional shootings, intimate partner violence, toxic stress, bullying, and mental health.

Increase funding for all federal health agencies to conduct public health research.
Strengthen laws and federally mandate extreme risk protection laws to assure firearm purchases are temporarily prohibited for individuals at high risk for harming themselves or others as well as those with restraining orders or convictions of family violence, domestic violence, and stalking.

Require universal background checks for all gun sales, from licensed and unlicensed dealers.

Establish a comprehensive definition for “semi-automatic assault weapons” and high-capacity magazines and create policies to regulate firearms being manufactured or converted at home to automatic weapons.

Reenact provisions of the Public Safety and Recreational Firearms Use Protection Act, specifically Title IX, Subtitle A of the Violent Crime Control and Law Enforcement Act (Public Law 103-322).[1]

Increase the age limit for all firearm purchases to 21 years of age.
Expand mental health services for all, including individuals at risk of committing acts of violence.

Increase funding for and create evidence-based violence prevention and intervention programs such as the Family Violence Prevention and Services Program that are rigorously evaluated.[2]

[1] H.R.3355 – 103rd Congress (1993-1994): Violent Crime Control and Law Enforcement Act of 1994. (1994, September 13). http://www.congress.gov/
[2] U.S. Department of Health and Human Services. (2021, October 29) Family Violence Prevention &; Services. The Administration for Children and Families. Retrieved from: https://www.acf.hhs.gov/fysb/programs/family-violence-prevention-services

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy